CTLA4 anticorps (AA 182-210)

N° du produit ABIN7871464

Cet anticorps anti-CTLA4 Polyclonal Lapin (ABIN7871464) détecte spécifiquement CTLA4 dans WB et IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour CTLA4 anticorps (AA 182-210) (ABIN7871464)

Antigène: CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CTLA4 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-CTLA4 anticorps

Épitope: AA 182-210

Fonction: CTLA4 Antibody / Cytotoxic T-lymphocyte protein 4 / CD152

Purification: Antigen affinity

Immunogène: A portion of amino acids 182-210 from the human protein was used as the immunogen for this CTLA4 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Titration of the CTLA4 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Aliquot the CTLA4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur CTLA4

Antigène: CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Autre désignation: CTLA4

Sujet: CTLA4 is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer.

UniProt: P16410

Pathways: Cancer Immune Checkpoints